Furthermore, we suggest that multitracer PET studies will be useful to formally assess how neuroinflammation relates to other important molecular aspects in dementia and related disorders including, for example, studying how neuroinflammation is associated with amyloid load in AD14 as well as with tau burden in AD and PSP. The gene discussed is MAPT; the disease is dementia.